STTK: Shattuck Therapeutics Sotuvga nisbatan narx
Shattuck Labs, Inc. (STTK) saraton bilan kurashish uchun ikki funksiyali protein platformasini ishlab chiqmoqda, bu esa strategik sherikliklar uchun yo'l ochmoqda. GURU.Markets terminali sotuvlar nisbatidagi narx tendentsiyasini ko'rsatadi, bunda 456.70 joriy ko'rsatkichni ifodalaydi. Yuqori patent to'siqlari va FDA nazorati raqobatchilarning kirishini cheklaydi, biologik mahsulotlarni tashish paytidagi qat'iy harorat nazorati esa ularning to'liq butunligini ta'minlaydi.
Shattuck Labs, Inc. (STTK) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Shattuck Labs, Inc.|STTK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati shattucklabs.com|STTK - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Shattuck Therapeutics|STTK - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Shattuck Labs|Tezkor likvidlik ko‘rsatkichi shattucklabs.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
STTK - Kompaniyaning sof foydasi|Prognoz qilingan kelajakdagi foyda Shattuck Labs, Inc.|STTK - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori shattucklabs.com|STTK - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Shattuck Therapeutics|STTK - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Shattuck Labs|STTK - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi shattucklabs.com|STTK - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Shattuck Labs, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:Shattuck Labs Inc
P/S koeffitsiyenti biznesning bozor qiymatini uning daromadlariga nisbatan belgilaydi va savdoning har bir birligi uchun to'langan premiumni baholash imkonini beradi. Sotuvlar nisbatidagi narx metrikasini tahlil qilish aksiyalar kotirovkalari va haqiqiy moliyaviy oqimlar o'rtasidagi nomutanosibliklarni aniqlashga yordam beradi. Ushbu metrika bozor kapitalizatsiyasini yillik aylanmaga bo'lish orqali hisoblanadi va bozorning investitsiya kutib-kutishlarini o'lchaydi. Shattuck Labs, Inc. (STTK) uchun ushbu ko'rsatkich klinik sinovlarda immunoterapiya samaradorligi tasdiqlangunga qadar GADLEN platformasining spekulyativ qiymatini aks ettiradi.
Shattuck Labs, Inc. kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Protagonist Corp PTGX|IMVT: P/S multiplikatori|kiniksa.com - Bozor kapitallashuvining daromadga nisbati|GRFS (Grifols) - P/S multiplikatori|P/S multiplikatori Adaptive Biotech|Kapitalizatsiyaning daromadga nisbati CLDX (Celldex)|Kapitalizatsiyaning sotish hajmiga nisbati AUPH|BioCryst - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati VERA (veratx.com)|DNTH: Kapitalizatsiyaning daromadga nisbati|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Tourmaline|Narxning daromadga nisbati Precigen, Inc.|P/S multiplikatori pharming.com|Kapitalizatsiyaning daromadga nisbati NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Immunome Bio - Narxning daromadga nisbati|Gossamer Bio, Inc. - P/S multiplikatori|KALV - P/S multiplikatori|SEPN: P/S multiplikatori|PVLA (Pieris Pharma) - Narxning daromadga nisbati|Narxning daromadga nisbati Savara Corp|Rigel Corp (RIGL) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati ANAB (AnaptysBio, Inc.)|ATXS (astriatx.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENGN (enGene)|Narx/daromad koeffitsiyenti RAPT Therapeutics Inc. (RAPT)|JBIO - Narxning daromadga nisbati|ACRS (Aclaris Therapeutics, Inc) - Kapitalizatsiya va daromad nisbati|KYTX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati tizianalifesciences.com|Kapitalizatsiyaning daromadga nisbati CABA|Ventyx Biosciences Inc. (VTYX) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Theratechnologies Inc (THTX)|Narx/daromad koeffitsiyenti Avalo Therapeutics Inc|Eledon Pharmaceuticals - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati AGEN (agenusbio.com)|CLYM: Kapitalizatsiyaning daromadga nisbati|Zura Bio Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|aTyr (ATYR) - Narxning daromadga nisbati|Adagene Inc. (ADAG) - P/S multiplikatori|Narxning daromadga nisbati ImageneBio|Equillium Bio - Narxning sotuvga nisbati|P/S multiplikatori CNTB|IMUX (immunic-therapeutics.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ATRA (Atara Bio)|P/S multiplikatori InflaRx NV IFRX|XFOR - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACET (Adicet Bio)|celularity.com (CELU) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati INmune Bio Inc|BRNS (Barinthus Bio) - P/S multiplikatori|P/S multiplikatori Kezar Life Sciences Inc|Kapitalizatsiyaning daromadga nisbati SABS (SAB Biotherapeutics)|AKTX (akaritx.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd.)|Narx/daromad koeffitsiyenti Q32 Bio Inc (QTTB)|GOVX - Narxning daromadga nisbati|Edesa Biotech Corp (EDSA) - Kapitalizatsiyaning daromadga nisbati|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Carisma Therapeutics Inc.|Kapitalizatsiyaning daromadga nisbati XTLB|P/S multiplikatori Bolt Bio|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|aptevotherapeutics.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori AIM (AIM ImmunoTech Inc.)|Aditxt Inc. (ADTX) - Sotuvga nisbatan narx|GRI - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti XORTX Therapeutics Inc XRTX|HIND: P/S multiplikatori|Revelation Biosciences Corp - Bozor kapitallashuvining daromadga nisbati|INDP (Indaptus Therapeutics) - P/S multiplikatori|P/S multiplikatori scinai.com|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati AFMD|Allakos - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati HOOK (HOOKIPA Pharma, Inc.)|IGMS: Kapitalizatsiyaning daromadga nisbati|ITOS - P/S multiplikatori|OCEA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati TC BioPharm (Holdings) Plc|Narxning daromadga nisbati Third Harmonic Bio, Inc
